Skip to main content
. 2020 Sep 22;11(9):785. doi: 10.1038/s41419-020-02997-7

Fig. 2. FAS is the target of miR-196b-5p and is downregulated in non-small cell lung cancer (NSCLC).

Fig. 2

a FAS expression in A549 and H292 lung cancer cells after overexpressing miR-196b-5p was determined by qRT-PCR. Results are represented as means ± SD (n = 3). b Western blot analysis of FAS protein in A549 and H292 lung cancer cells after overexpressing miR-196b-5p. The bands were quantified using Image J software, and relative values were obtained by normalizing to the value of each corresponding GAPDH. c Expression level of FAS in 60 paired NSCLC tissues and their matched NATs. The RNA samples were extracted from 30 NSCLC tissues and 30 corresponding NATs. The RNAs were subject to qRT-PCR with a FAS probe, and the expression was normalized by GAPDH. d Upper panel shows representative immunohistochemical staining for FAS in NSCLC tissues and normal adjacent tissues (NATs) from the same patient. Summary of tissue immunohistochemical staining data for FAS in 48 pairs of clinical NSCLC tissues and NATs are shown in the lower panel. **P < 0.01, ***P < 0.001.